Skip to main content

Emergent BioSolutions Inc 10-Q for FY2021 Q3

Emergent BioSolutions Inc. (EBS)

10-Q 2021-11-05 For: 2021-09-30
View Original
Added on April 01, 2026

About this 10-Q

Emergent BioSolutions Inc filed this 10-Q on November 5, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).

Headline figures

Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$329M
down 14.6% from $385.2M a year earlier
Net loss
$32.7M
compared with net income of $39.5M a year earlier
Diluted EPS
-$0.61
compared with $0.73 a year earlier